Mayo Clinic gastroenterologist and professor of medicine Dr. Paul Limburg has joined Exact Sciences Corp. as co-chief medical officer. Limburg, a co-leader of the Cancer Prevention and Control program in the Mayo Clinic Cancer Center, will continue in his positions at Mayo in addition to his...
Irving Shain, a chemistry professor and UW–Madison chancellor emeritus who advanced the university’s interests in China and established University Research Park, died peacefully Tuesday, March 6, in Madison after a brief illness. He was 92. Irving Shain at a 1978 commencement ceremony. Photo: Norman Lenburg/UW–Madison Archives Shain...
LIVABILITY polls the nation each year to find out what matters most in communities throughout the U.S. Is health care most important, or affordable housing? Which matters more, commute times or climate? They then source the best public and private data available to find the...
Fifty entries from 28 communities have advanced to the semi-final round of the 15th annual Wisconsin Governor’s Business Plan Contest, contest producers announced. The contestants were selected from a field of about 200 qualified first-round entries by an independent panel of 110 judges organized through the Wisconsin Technology...
Article courtesy of WisBusiness.com Contributors include university researchers, teachers, business leaders and entrepreneurs, public officials and investors. Their writings focus on the "crucial interdependence" between innovations pioneered at the UW System and the strength of the state's economy. "The voices we have collected exemplify the strength, power...
Science moves. It unlocks mysteries in medicine and opens new doors in human health. But science doesn’t thrive by asking safe questions. It moves when we push fearlessly into frontiers. This Spring 2018 report explores science with the promise to move our lives. LEARN MORE - OR...
MADISON, Wis., Feb. 22, 2018 -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $266 million and completed approximately 571,000 Cologuard tests during the year ended Dec. 31, 2017. Full-year 2017 revenue and Cologuard test volume grew 168 percent and...
A whole-virus vaccine to confront Ebola, the rare but often fatal hemorrhagic disease that periodically erupts in sub-Saharan Africa, may soon be one step closer to the clinic. With the help of experts at Waisman Biomanufacturing, within the University of Wisconsin-Madison’s Waisman Center, UW-Madison School of...
A whole-virus vaccine to confront Ebola, the rare but often fatal hemorrhagic disease that periodically erupts in sub-Saharan Africa, may soon be one step closer to the clinic. With the help of experts at Waisman Biomanufacturing, within the University of Wisconsin–Madison’s Waisman Center, UW–Madison School of Veterinary...
Every five years, the UW Carbone Cancer Center receives a thorough check-up from the nation’s top cancer researchers. Leaders recently learned that it passed its review with flying colors and will retain its designation as Wisconsin’s only National Cancer Institute (NCI) Comprehensive Cancer Center and $27 million in core funding. “We...
ExpressGraft-C9T1 is being used in first-round tests on a patient with diabetic foot ulcers — open sores that can affect patients with diabetes and can lead to amputation, said Mallinckrodt, the global pharmaceutical company whose Madison division, formerly Stratatech Corp., developed the tissue. ExpressGraft-C9T1 is a...
Xconomy Wisconsin — Fujifilm said it plans to use stem cells developed by Cellular Dynamics International, a Wisconsin-based company it owns, as part of a new partnership between Fujifilm and Takeda Pharmaceutical that’s aimed at developing regenerative medicine therapies. Takeda and Fujifilm, both headquartered in Japan,...